Objective: To evaluate the the effect of two blood purification in patients with chronic renal failure uremia. Methods: One hundred cases of patients from April 2012 to February 2014 in our hospital were chosen as the experimental object, and were divided into experimental group and control group, control group were treated with hemodiafiltration, and the experimental group were treated with high-flux hemodialysis,the serum medium and small molecule toxins and cognitive function improvement were compared. Results:The serum medium and small molecule toxins and cognitive function of two group were greatly improved, there were significant differences(t=4.113, t=0.430, t=1.038, t=0.346; P<0.05).The experimental group after treatment, serum phosphorus, parathyroid hormone was lower than the control group, the difference was statistically significant (t=-4.189, t=4.113;P<0.05). The experimental group PL and Amp were better than the patients in the control group, the difference was statistically significant (t=15.023, t=3.428; P<0.05). Conclusion: Two blood purification has good effect on treating patients with chronic renal failure uremia, but the improving effect of high flux hemodialysis scavenging effect on cysC, parathyroid hormone and serum phosphorus and cognitive function are better than that of hemodiafiltration.

Objective To compare the efficacy and toxicity of thalidomide-COMP (T-COMP) and thalidomide-VAD (T-VAD) regimens in previously untreated multiple myeloma (MM) patients.Methods Forty-nine newly diagnosed MM patients were randomly allocated to either A group (thalidomide-MP/-COMP,19 cases) or B group (thalidomide-VAD,30 cases).All patients received thalidomide 200 mg p.o.daily.Patients in group A received additionally vincristine 0.4 mg i.v.on day 1-4,cyclophosphamide 200 mg i.v.on day 1-4,melphalan 4 mg tid p.o.on days 1-5,prednisone 60 mg p.o.daily on days 1-5.Patients in group B received additionally vincristine 0.4 mg i.v.on day 1-4 and epirubicin 10 mg/m2 i.v.,on day 1-4 and dexamethasone 40 mg p.o.daily on days 1-4,9-12 and 17-20 for the first cycle and on days 1-4 for the next three cycles.Treatment was administered every 28 days.The therapeutic response was evaluated based on the International Myeloma Working Group Criteria (IMWG 2006) after the treatment.The toxicity was graded according to NCI common terminology criteria for adverse events v 3.0.Results On an intention-to-treat basis,at least partial therapeutic response was observed.The rates were 73.7 ％ and 53.3 ％ in group A and B respectively (x2 =2.029,P =0.154).Overall survival (OS) rate at 2 years were 52.6 ％ (10/19) in group A and 53.3 ％ (16/30) in group B,respectively (x2 =2.468,P =0.116).Considering overall toxicity,constipation,peripheral neuropathy,dizziness/somnolence,skin rash and edema were significantly higher in group B compared with group A,but the incidence of toxicities grade 3-4 was low and similar in both arms.Conclusion The overall response rate of T-MP/T-COMP regimen is similar with that of T-VAD regimen,suggesting this regimen cannot be chosen as the first treatment for patients with non-implantation therapy.

Objective To assess the efficacy of high dose dexamethasone combined with bortezomib and thalidomide in multiple myeloma (MM) patients with acute renal failure.Methods 23 newly diagoosed MM patients with acute renal failure were treated with high dose dexamethasone combined with bortezomib and thalidomide.Results Reversal of renal failure was documented in 58.3 ％ (7/12) of those severe renal failure patients and 81.8 ％ (9/11) of renal failure patients.Renal function was reversed in 69.5 ％ (16/23) of all patients.The total response rate for MM was 60.9 ％ (14/23).The median time to response was 2 (1-5) months. Overall survival (OS) at 3 years was 56.5 ％ and the median survival time was 34.4 months.Conclusion Renal failure was reversible in the majority of newly diagnosed MM patients treated with highdose dexamethasone containing regimens.The addition of novel agents thalidomide and (or) bortezomib is safe and induces a more rapid renal failure reversal compared with routine chemotherapy.

Along with the progress of Chinese pharmaceutical industry, as well as the development of natural products in the world, the need of medicinal plant resources is increasing, which results in the ruinous destruction of endangered medicinal plants. The field cultivation and wild tending cultivation could not solve all the resource problems and the help with bioengineering technolgy will be needed in this field. Micropropagation could quickly supply the shoots with good quality medicinal plants by two ways, the shoot and root induction through callus or the other is shoot development by somatic embryos. The regenerated shoots could be transferred into the field for the base of field cultivation or tending cultivation. In addition, the active compounds could be produced by the cultivated medicinal plant cells, tissues, or organs in bioreactor, which could decrease the cost at industrial level. In China, the bioengineering technology should be developed and applied to the medicinal plants development, because the most resources to support the whole traditiolal Chinese medicine will be utilized, moreover, in China the most amount of extracts from medicinal plants are used and exported all over the world.

Objective To explore the effects of enalapril on spatial learning and memory,and to identify synaptophysin expression in hippocampus of streptozotocin-diabetic rats.Methods Forty rats were randomly divided into control group,diabetic model group and the enalapril treatment group.Streptozotocin-diabetic rat model was developed.The diabetic rats were treated with enalapril for 12 weeks.Then,the learning and memory abilities of rats were tested with Morris water maze;mRNA and protein expression of synaptophysin in hippocampus was detected by RT-PCR and immunostaining.Results Compared with diabetic model group,the enalapril treatment group showed a significant decrease in the mean time of escape latencies(P

Objective To analyze palm ratio of body surface area (B SA ) based on the body different surface area form ula. Methods Forty-four Chinese adult m ales w ere selected in this study. The contour of left single palm w as recorded and the palm area w as calculated by cut-paper w eighing m ethod. The body surface w as calculated by the height and w eight based on 12 form ulas of body surface area. Then, the palm ratio of BSA w as calculated. Results The average palm ratio of BSA w as (0.789±0.075)% . The data show ed statistically significant difference com pared with the traditional ratio (1% ) (P<0.05). Conclusion The ratio of B SA in Chinese adult m ale population show ed m ore accuracy com pared with the traditional ratio in this present study. The forensic evaluation can be affected by using the different ratio of B SA .

OBJECTIVE: To analyze palm ratio of body surface area (BSA) based on the body different surface area formula. METHODS: Forty-four Chinese adult males were selected in this study. The contour of left single palm was recorded and the palm area was calculated by cut-paper weighing method. The body surface was calculated by the height and weight based on 12 formulas of body surface area. Then, the palm ratio of BSA was calculated. RESULTS: The average palm ratio of BSA was (0.789 ± 0.075)%. The data showed statistically significant difference compared with the traditional ratio (1%) (P < 0.05). CONCLUSION The ratio of BSA in Chinese adult male population showed more accuracy compared with the traditional ratio in this present study. The forensic evaluation can be affected by using the different ratio of BSA.
Adult ; Asian People ; Body Height ; Body Surface Area ; Body Weight ; Hand/anatomy & histology* ; Humans ; Male

3D printing technology has become the focus of the study on rapid proyotyping technology in recent years. This paper introduced the principle, material and equipments of 3D printing, as well as the foot orthosis. This paper also summarized the application of 3D printing in custom-made foot orthosis, and the differences between 3D printing and traditional technology from the aspect of structure design, material, and clinical application, etc., and discussed the problems and future development of 3D printing.

Objective To evaluate the cranioplasty with Titanium mesh.Methods Clinical studies of 110 cases who accepted cranioplasty with Titanium mesh (2000-2001) were reviewed retrospectively.Results A satisfactory moulding with no complication occurred in 91%(100/110). The most common recent complication of cranioplasty with Titanium was subcutaneous hematoma(19/110); the next was epidural hematoma(3/110), intracerebral hematoma(3/110) and brain contusion(1/110). 69 cases more than 1 year after cranioplasty were followed, no one appeared long term complications such as infection, exposure or mobilization of the mending material.Conclusion The results of cranioplasty with Titanium mesh are satisfactory, the recent complications of the operation are mainly related to incompletely hemostasis, the long term complication occurred rarely.

Objective:To observe the effects of rosiglitazone on transforming growth factor-?1(TGF-?1)/SMADs signal pathway in dia- betic rat myoeardium(DM)and cardiac remodeling. Methods:Thirty male SD rats were randomly divided into normal control,DM and rosiglitazone groups,each having 10 rats.Diabetic rats were induced by a single intrapefitoneal injection of streptozotoein(60mg/kg).A cannula connected to a trans- ducer was inserted into the heart to measure the cardiac function.The body weight,heart weight and heart weight/body weight (HW/BW)were measured.The ultrastruetural changes were evaluated by electron microscope and collagen content was assessed by Van Gieson staining.The mRNA expression level of SMAD3 and SMAD7 were determined by RT-PCR.The protein level of TGF-?1,SMAD3 and SMAD7 were detected by immunohistochemistry. Results:Compared with the normal controls,diabetic rats experienced marked myocardium damage.Cardiac function,espe- cially diastolic function was impaired,HW/BW(P